학술논문
PCN35 A COST UTILITY ANALYSIS OF FULVESTRANT VERSUS EXEMESTANE IN THE SECOND LINE TREATMENT OF POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST CANCER IN GREECE (PRELIMINARY RESULTS)
Document Type
Abstract
Source
In Value in Health 2005 8(6):A44-A44
Subject
Language
ISSN
1098-3015